Genus plc (LON:GNS)
London · Delayed Price · Currency is GBP · Price in GBX 2,194.00
-50.00 (-2.23%)
Jul 31, 2026, 5:10 PM GMT
Genus Market Cap
Genus has a market cap or net worth of 1.47 billion as of July 31, 2026. Its market cap has decreased by -9.88% in one year.
Market Cap
1.47B
Enterprise Value
1.69B
Revenue
672.00M
Ranking
n/a
PE Ratio
30.97
Stock Price
2,194.00
ChartMarket Cap Chart
Since January 30, 1998, Genus's market cap has increased from 31.03M to 1.47B, an increase of 4,631.73%. That is a compound annual growth rate of 14.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 1.47B | -15.44% |
| Dec 31, 2025 | 1.74B | 70.54% |
| Dec 31, 2024 | 1.02B | -28.43% |
| Dec 29, 2023 | 1.42B | -27.10% |
| Dec 30, 2022 | 1.95B | -39.35% |
| Dec 31, 2021 | 3.22B | 18.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oxford Nanopore Technologies | 1.11B |
| Oxford Biomedica | 677.81M |
| Avacta Group | 311.49M |
| PureTech Health | 289.67M |
| Scancell Holdings | 118.19M |
| Faron Pharmaceuticals Oy | 94.23M |
| 4basebio | 81.58M |
| Bioventix | 78.90M |